Fentanyl remaining in a transdermal system following three days of continuous use

Ann Pharmacother. 1995 Oct;29(10):969-71. doi: 10.1177/106002809502901001.

Abstract

Objective: To determine whether there was a sufficient amount of fentanyl remaining in a patch that had been used continuously for 3 days to warrant establishment of disposal policies to prevent diversion of fentanyl.

Design: Nine patches were applied and removed by hospice nurses after 3 days of continuous use on hospice patients with cancer. Patches were analyzed for the remaining fentanyl contents using the Coat-A-Count Fentanyl radioimmunoassay. Five 2.5-mg patches and four 10.0-mg patches were opened, solubilized with methanol, diluted with water, and analyzed in duplicate. An unused 2.5-mg patch also was analyzed as a control and showed a 94% recovery of fentanyl. A methanol blank was negative for fentanyl.

Main outcome measures: The study determined the amount of fentanyl in milligrams remaining in a used patch. Using pharmacokinetics principles, this quantity was compared with a potential lethal dose of fentanyl.

Results: Analysis showed 0.7-1.22 mg remaining in the 2.5-mg patches and 4.46-8.44 mg remaining in the 10.0-mg patches. These numbers represent 28-84.4% of the original contents. Using the pharmacokinetic values of the volume of distribution of 4L/kg and a potential lethal blood concentration of 3.7 micrograms/L, one can calculate the potential lethal dose for a 70-kg person to be 1036 micrograms. This is well within the amount remaining in the patch. This study also demonstrated that a wide patient variability exists in the absorption of fentanyl from the patch.

Conclusions: There is a sufficient amount of fentanyl available for abuse and misuse after 3 days of therapeutic use. Adequate disposal policies currently are not established and need to be implemented.

MeSH terms

  • Administration, Cutaneous
  • Analgesics, Opioid / administration & dosage*
  • Analgesics, Opioid / analysis
  • Chronic Disease
  • Fentanyl / administration & dosage*
  • Fentanyl / analysis
  • Humans
  • Medical Waste Disposal
  • Neoplasms / physiopathology
  • Pain / drug therapy
  • Radioimmunoassay
  • Skin Absorption
  • Substance-Related Disorders / prevention & control
  • Time Factors

Substances

  • Analgesics, Opioid
  • Medical Waste Disposal
  • Fentanyl